(CIDRAP News) – A government advisory committee yesterday endorsed the safety and immunogenicity of an adjuvant-containing H5N1 influenza vaccine proposed for inclusion in the US pandemic emergency stockpile, signaling that it could become the first adjuvanted flu vaccine to win approval in the United States.
(CIDRAP News) The case count in the nationwide Salmonella outbreak tied to peanut butter climbed to 550 yesterday, as federal officials announced an effort to use "social media" such as podcasts and YouTube videos to keep consumers abreast of product recalls and other developments in the outbreak.
(CIDRAP News) – A flu vaccine manufacturer's decision not to build a US facility has highlighted the perpetual mismatch between flu-shot supply and demand—and the reality that the mismatch may undermine plans for pandemic flu vaccines.
(CIDRAP News) This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.
(CIDRAP News) – In an effort to expand the pool of antiviral drugs for influenza, the US government yesterday awarded a $102.6 million contract to BioCryst Pharmaceuticals Inc. of Birmingham, Ala., to develop peramivir, a new neuraminidase inhibitor.
(CIDRAP News) Canada announced yesterday it will ban cattle parts that could spread bovine spongiform encephalopathy (BSE) from all animal feeds, pet foods, and fertilizers, making Canada's restrictions tighter than those in the United States.